Treatment of Severe Pruritus in RLS Patients
Start with gabapentin or pregabalin as first-line therapy for your RLS patient's terrible itching, as these alpha-2-delta ligands are now the primary recommended treatments for RLS and may address both the movement disorder and associated sensory symptoms. 1
Understanding the Clinical Picture
The "terrible itching" you describe is likely part of the RLS symptom complex itself—RLS characteristically presents with dysesthesias (uncomfortable sensations) in the affected extremities that patients may describe as itching, crawling, or other unpleasant sensations. This is distinct from true dermatologic pruritus. The key diagnostic feature is that these sensations are relieved by movement and worsen with immobility, particularly in the evening/night 1.
First-Line Treatment Algorithm
Step 1: Check Iron Status Immediately
- Measure ferritin and transferrin saturation
- If ferritin < 75 ng/mL: Treat with iron supplementation to achieve ferritin > 100 ng/mL 1, 2
Step 2: Initiate Alpha-2-Delta Ligand Therapy
The 2025 AASM guidelines provide strong recommendations for:
- Gabapentin (strong recommendation, moderate certainty) 1
- Pregabalin (strong recommendation, moderate certainty) 1
These agents address the core RLS pathophysiology and should improve the dysesthetic symptoms (the "itching") along with the urge to move.
Critical Pitfall: Avoid Dopamine Agonists
Do NOT use dopamine agonists (pramipexole, ropinirole, rotigotine) as standard therapy 1. The 2025 guidelines represent a major paradigm shift—these agents are now conditionally recommended against for standard use due to the high risk of augmentation (worsening of symptoms with long-term use) 1, 3. This is a dramatic reversal from 2012 guidelines where they were first-line 1, 4.
Additional Treatment Options
If Inadequate Response to First-Line Therapy:
Extended-release oxycodone or other opioids (conditional recommendation, moderate certainty) 1
- Particularly useful if augmentation from prior dopamine agonist use
- Monitor for respiratory depression, especially with concurrent sleep apnea 1
Bilateral high-frequency peroneal nerve stimulation (conditional recommendation, moderate certainty) 1
- Can serve as adjunct therapy in refractory cases 4
Medications to Avoid:
- Do NOT use: Cabergoline (strong recommendation against) 1
- Do NOT use: Bupropion, carbamazepine, clonazepam, valproic acid (all conditional recommendations against) 1
Special Consideration: True Pruritus vs RLS Dysesthesia
If you suspect the itching is true dermatologic pruritus rather than RLS dysesthesia, gabapentin remains appropriate as it's recommended for neuropathic pruritus 5. However, the presence of RLS makes this distinction less critical since gabapentin addresses both conditions.
If Patient Has End-Stage Renal Disease
The treatment approach differs slightly:
- Gabapentin still recommended (conditional recommendation) 1
- IV iron sucrose if ferritin < 200 ng/mL and transferrin saturation < 20% (conditional recommendation) 1
- Consider vitamin C supplementation (conditional recommendation) 1
Implementation Strategy
- Today: Order ferritin and transferrin saturation
- Today: Start gabapentin (titrate to effect) or pregabalin
- When labs return: Add IV ferric carboxymaltose if ferritin < 75 ng/mL
- Reassess in 2-4 weeks: If inadequate response, consider adding opioid therapy or referral for device-based treatment
The evidence strongly supports this iron-conscious, alpha-2-delta ligand-first, augmentation-aware approach as the modern standard of care 3, 2.